Krystal Biotech, Inc. Common Stock insider trading
KRYSfinancial statementsForm 4 filings on EDGAR288 transactions since Nov 9, 2024
From August 12, 2026 to November 9, 2026, 0 insiders at Krystal Biotech, Inc. Common Stock bought $0 of stock in the open market, and 3 sold $26M. Officers and directors accounted for $0 of purchases and $26M of sales. The last reported transaction was an open-market sale by Krishnan Suma on September 4, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 4, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $26MAug 12, 2026 – Nov 9, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 6, 2026. Insider data through Nov 9, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
288 transactions from November 9, 2024 to November 9, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 520 | $354.54 | $184K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 2,006 | $355.57 | $713K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 3,267 | $356.37 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 3,962 | $357.57 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 3,180 | $358.42 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 3,392 | $359.39 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 2,320 | $360.47 | $836K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 1,242 | $361.61 | $449K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 1,992 | $362.65 | $722K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 565 | $363.34 | $205K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 1,329 | $364.48 | $484K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 826 | $365.41 | $302K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 399 | $366.56 | $146K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 520 | $354.54 | $184K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 2,029 | $355.57 | $721K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 3,297 | $356.37 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 3,981 | $357.57 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 3,143 | $358.42 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 3,357 | $359.39 | $1M | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 2,266 | $360.46 | $817K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 1,214 | $361.61 | $439K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 2,010 | $362.65 | $729K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 573 | $363.34 | $208K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 1,358 | $364.48 | $495K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 847 | $365.42 | $310K | 1M | Sep 4, 2026 |
| Sep 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 405 | $366.56 | $148K | 1M | Sep 4, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | gift | 3,691 | $0.00 | — | 75,000 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 341 | $325.60 | $111K | 74,659 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 2,287 | $326.60 | $747K | 72,372 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 5,226 | $327.39 | $2M | 67,146 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 1,687 | $328.52 | $554K | 65,459 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 7,428 | $329.60 | $2M | 58,031 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 4,896 | $330.36 | $2M | 53,135 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 3,095 | $331.43 | $1M | 50,040 | Aug 14, 2026 |
| Aug 14, 2026 | Rossi Dino A | Director | open-market sale | 40 | $333.23 | $13K | 50,000 | Aug 14, 2026 |
| Jun 25, 2026 | Thomas John Charles | EVP, General Counsel | option exercise | 1,000 | $179.25 | $179K | 1,000 | Jun 26, 2026 |
| Jun 25, 2026 | Thomas John Charles | EVP, General Counsel | open-market sale10b5-1 | 1,000 | $347.27 | $347K | 0 | Jun 26, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 320 | $300.75 | $96K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 593 | $302.25 | $179K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 247 | $303.17 | $75K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 400 | $304.89 | $122K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 480 | $305.87 | $147K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 1,348 | $307.09 | $414K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 12,729 | $307.81 | $4M | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 3,803 | $308.89 | $1M | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 2,801 | $309.95 | $868K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 2,039 | $310.94 | $634K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Suma | President, R&D, Director, 10% owner | open-market sale10b5-1 | 240 | $311.65 | $75K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 320 | $300.75 | $96K | 1M | Jun 5, 2026 |
| Jun 4, 2026 | Krishnan Krish S | President and CEO, Director, 10% owner | open-market sale10b5-1 | 640 | $302.24 | $193K | 1M | Jun 5, 2026 |
Who the insiders are
Everyone who reported a transaction since November 9, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Krishnan Suma | President, R&D, Director, 10% owner | Sep 4, 2026 | open-market sale | 1M | — | $34M (50) | 50 of 50 |
| Krishnan Krish S | President and CEO, Director, 10% owner | Sep 4, 2026 | open-market sale | 1M | — | $34M (50) | 50 of 50 |
| Janney Daniel | Director | Feb 27, 2026 | open-market sale | 0 | — | $19M (22) | 22 of 22 |
| Rossi Dino A | Director | Aug 14, 2026 | gift | 75,000 | — | $13M (10) | 0 of 10 |
| Romano Kathryn | Chief Accounting Officer | Mar 2, 2026 | open-market sale | 22,366 | — | $4M (8) | 8 of 8 |
| Thomas John Charles | EVP, General Counsel | Jun 25, 2026 | option exercise | 1,000 | — | $541K (2) | 2 of 2 |
Questions
Are Krystal Biotech, Inc. Common Stock insiders buying or selling?
Over the twelve months to November 9, 2026, 6 insiders at Krystal Biotech, Inc. Common Stock sold $105M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $105M. Only open-market purchases and sales are counted.
Who sold the most Krystal Biotech, Inc. Common Stock stock in the last year?
Krishnan Suma (President, R&D, Director, 10% owner) sold $34M in 50 open-market sales over the twelve months to November 9, 2026.
Do Krystal Biotech, Inc. Common Stock executives sell under 10b5-1 plans?
132 of the 142 open-market sales in the last twelve months (93%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Krystal Biotech, Inc. Common Stock
- Krystal Biotech, Inc. Common Stock financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.